Arm Systems For Medical Surgeries Articles & Analysis
6 news found
RTI Group, a global leader in Quality Assurance (QA) of X-ray imaging, proudly announces a landmark year marked by exceptional financial performance, significant market expansion, and strategic innovations. The company exceeded its revenue target, achieving over 125 million SEK in 2024, representing a remarkable growth of more than 20 percent compared to the previous ...
We are proud to announce that the RTI Calibration Laboratory in Mölndal, Sweden, has officially achieved ISO 17025 accreditation for Half Value Layer (HVL) calibration. This milestone allows us to expand our services, offering customers accredited HVL calibration alongside our existing ISO 17025 accredited calibrations for Tube Voltage, Air Kerma, mA/mAs, Luminance, and ...
Gières (Grenoble), France, December, 14 2021 The funds will enable eCential Robotics to invest in research and development to offer a fully unified and comprehensive robotic solution for less invasive surgical procedures, assisting surgeons from planning through to execution. The operation comes under secured global financing of close to €100 million in equity, quasi-equity ...
Ivantis Inc., developer of the novel Hydrus® Microstent, a minimally invasive glaucoma surgery (MIGS) device intended to lower eye pressure for open-angle glaucoma patients, has announced new data from its five-year HORIZON pivotal trial showing that the Hydrus Microstent lowers the rate of visual field loss by 47% versus cataract surgery alone. The breakthrough findings position the ...
Ivantis Inc., developer of the novel Hydrus® Microstent, a minimally invasive glaucoma surgery (MIGS) device designed to lower eye pressure for open-angle glaucoma patients, announced today the first-ever release of five-year follow-up data from its HORIZON pivotal trial. This significant milestone represents the longest continuous follow-up of a MIGS device pivotal trial and comes on the ...
Ivantis Inc., developer of the novel Hydrus® Microstent, a minimally invasive glaucoma surgery (MIGS) device intended to lower eye pressure for open-angle glaucoma patients, announced today that the American Academy of Ophthalmology (AAO) has designated the Hydrus Microstent as “Level 1, Moderate Quality, Strong Recommendation” — the highest designation of any MIGS device ...